English
-
Dealing with Dengue
-
-
Clinical diagnosis and management of dengue
PAHO -
Dengue Clinical Case Management
CDC -
Dengue: diagnosis and treatment updates
ISID62 minutes -
Dengue diagnosis: unique challenges in a time of a pandemic
Medscape15 minutes -
Management of cases
Takeda1 minutes -
Zika and dengue but not chikungunya are associated with Guillain–Barré syndrome in Mexico: A case-control study
Takeda2 minutes -
Experience of a tertiary hospital in Singapore managing a dual outbreak of COVID and dengue
Takeda2 minutes -
The COVID-19 pandemic should not jeopardize dengue control
Takeda2 minutes -
Managing the severely ill dengue patients – Adult and Paediatric Intensivists
ADVA92 minutes -
Case report: Acute vision loss in a young returning traveler with dengue fever
Takeda2 minutes -
Randomised trials of Wolbachia for dengue control – a step towards elimination?
ADVA50 minutes -
Covid-19 and dengue: Double punches for dengue-endemic countries in Asia
Takeda2 minutes -
Impact of the COVID-19 Pandemic on the Global Dengue Situation
ADVA79 minutes -
Mosquito-Borne Viral Diseases: Advice for Travelers to Endemic Areas
Medscape35 minutes -
Emerging Issues in Pediatric Dengue
WSPID50 minutes -
Dengue incidence rates in travelers
Takeda2 minutes -
Wanderlust meets dengue: what you need to consider as HCP?
Takeda10 minutes -
Effects of dengue
Takeda7 minutes -
Prevention of dengue
Takeda6 minutes
Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda
© Copyright 2023 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2021